Implanted Pacing System Attaches Directly to Heart
By HospiMedica International staff writers Posted on 15 Feb 2017 |

Image: The Micra TPS alongside a vitamin capsule (Photo courtesy of Medtronic).
A novel leadless pacemaker provides patients with advanced pacing technology at one-tenth the size of a traditional pacemaker.
The Medtronic Micra Transcatheter Pacing System (TPS) is s a fully self-contained, miniaturized pacemaker designed to provide patients with bradycardia an advanced single chamber pacing technology via a minimally invasive approach. The size of a large vitamin capsule, it does not require electrical leads to deliver pacing therapy, attaching instead directly to the heart wall via small nitinol wires (tines) that hold the device and the electrodes in place.
The Micra TPS is delivered via a percutaneous catheter through the femoral vein and positioned inside the right ventricle of the heart. It does not require a surgical “pocket” to be created under the skin, eliminating potential complications, and can be repeatedly repositioned to make sure heart activity and low electrical thresholds are optimal. Once positioned, the device responds to patients' activity levels by automatically adjusting therapy. The Micra TPS has an estimated 12-year battery life, and is approved for full body 1.5 and 3 Tesla scans magnetic resonance imaging (MRI) scans.
“Dating back to the development of the first external battery operated pacemaker more than 60 years ago, Medtronic has a long history of collaborating with clinicians to better understand the needs of patients, and then innovating new products to meet those needs,” said John Liddicoat, MD, senior vice president and president of the cardiac rhythm and heart failure division at Medtronic. “We're looking forward to working with physicians and educating implanters to extend the positive results of our global clinical trial experience to even more patients.”
“The device is small enough to be delivered through a catheter and implanted directly into the heart, providing a safe alternative to conventional pacemakers without the complications associated with leads,” said cardiologist Paul Schurmann, MD, of Houston Methodist Hospital. “The device also allows us to automatically adjust pacing therapy based on a patient's activity levels and another positive is the battery can last up to 10 years. I believe this gives us another tool to help save lives of patients with slow or irregular heart rhythms.”
Bradycardia is defined as a heart rate of under 60 beats per minute (BPM) in adults. It typically does not cause symptoms until the rate drops below 50 BPM. Symptoms include fatigue, weakness, dizziness, and at very low rates, fainting. Highly trained athletes may also have athletic heart syndrome, a very slow resting heart rate that occurs as a sport adaptation and helps prevent tachycardia during training.
The Medtronic Micra Transcatheter Pacing System (TPS) is s a fully self-contained, miniaturized pacemaker designed to provide patients with bradycardia an advanced single chamber pacing technology via a minimally invasive approach. The size of a large vitamin capsule, it does not require electrical leads to deliver pacing therapy, attaching instead directly to the heart wall via small nitinol wires (tines) that hold the device and the electrodes in place.
The Micra TPS is delivered via a percutaneous catheter through the femoral vein and positioned inside the right ventricle of the heart. It does not require a surgical “pocket” to be created under the skin, eliminating potential complications, and can be repeatedly repositioned to make sure heart activity and low electrical thresholds are optimal. Once positioned, the device responds to patients' activity levels by automatically adjusting therapy. The Micra TPS has an estimated 12-year battery life, and is approved for full body 1.5 and 3 Tesla scans magnetic resonance imaging (MRI) scans.
“Dating back to the development of the first external battery operated pacemaker more than 60 years ago, Medtronic has a long history of collaborating with clinicians to better understand the needs of patients, and then innovating new products to meet those needs,” said John Liddicoat, MD, senior vice president and president of the cardiac rhythm and heart failure division at Medtronic. “We're looking forward to working with physicians and educating implanters to extend the positive results of our global clinical trial experience to even more patients.”
“The device is small enough to be delivered through a catheter and implanted directly into the heart, providing a safe alternative to conventional pacemakers without the complications associated with leads,” said cardiologist Paul Schurmann, MD, of Houston Methodist Hospital. “The device also allows us to automatically adjust pacing therapy based on a patient's activity levels and another positive is the battery can last up to 10 years. I believe this gives us another tool to help save lives of patients with slow or irregular heart rhythms.”
Bradycardia is defined as a heart rate of under 60 beats per minute (BPM) in adults. It typically does not cause symptoms until the rate drops below 50 BPM. Symptoms include fatigue, weakness, dizziness, and at very low rates, fainting. Highly trained athletes may also have athletic heart syndrome, a very slow resting heart rate that occurs as a sport adaptation and helps prevent tachycardia during training.
Latest Critical Care News
- New Approach to Visualizing Blood Pressure Data Can Help Better Manage Hypertension Patients
- Breakthrough AI Technology Accurately Assesses Heart Failure Severity
- Smart Bandage Monitors Chronic Wounds in Human Patients
- AI Identifies Patients with Increased Lung Cancer Risk Up To 4 Months Earlier
- Next Gen Hemodynamic Monitoring Solution Provides AI-Driven Clinical Decision Support
- AI Algorithm Identifies High-Risk Heart Patients
- Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk
- Wireless, Self-Powered Smart Insole to Improve Personal Health Monitoring
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
Channels
Surgical Techniques
view channel
DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more